QuickView for anticarcinogenic protease inhibitors

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. Broad Connectivity Map (CMAP 2.0) compound database
4. Drug target sets for approved compounds
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]

1. Black tea polyphenols inhibit tumor proteasome activity.
2. Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in co…
3. Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-de…
4. Three-dimensional cell culture array using magnetic force-based cell patterning for analysis of inva…
5. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death.

There were no clinical trials for anticarcinogenic protease inhibitors